Background Info
Maternally Acquired Antibodies
Humoral antibodies of the IgG class can cross the placenta from mother to foetus.[^3]
These antibodies will provide passive protection of the newborn against those diseases which involve humoral immunity and to which the mother is immune.[^3]
In this manner, most newborn infants in the UK will have passive protection against tetanus, but not against tuberculosis. Protection against the latter relies to a large extent on cell-mediated immunity.[^3]
Secreted (IgA) antibodies are also passed to the gut of a newborn, together with the first deliveries of breast milk (colostrum). Such antibodies provide some passive protection against infections of the gastrointestinal tract.[^3]
Interaction with Vaccines
Maternally acquired antibodies will react with antigens associated with an infection but also with antigens introduced to the body as part of an immunisation programme. Premature immunisation, that is, before degradation of the maternal antibodies, may reduce the potency of an administered vaccine.[^3]
Immunization Schedule
Vaccines Recommended from birth to 18 years:[1]
- Hepatitis B (HepB)
- Rotavirus (RV) RV1 (2-dose series); RV5 (3-dose series)
- Diphtheria, Tetanus, Acellular pertussis (DTaP)
- Haemophilus influenzae type b (Hib)
- Pneumococcal conjugate (PCV13)
- Inactivated poliovirus (IPV)
- Influenza (IIV4)
- Influenza (LAIV4)
- Measles, mumps, rubella (MMR)
- Varicella (VAR)
- Hepatitis A (HepA)
- Tetanus, diphtheria, & acellular pertussis (Tdap)
- Human papillomavirus (HPV)
- Meningococcal (MenACWY-D, MenACWY-CRM, MenACWY-TT)
- Meningococcal B (MenB-4C, MenB-FHbp)
- Pneumococcal polysaccharide (PPSV23)
- Dengue (DEN4CYD)
Title: Hugo and Russell’s Pharmaceutical Microbiology, 9th Edition
Publication: John Wiley & Sons
Date: Apr 24, 2023
Author(s): Brendan F. Gilmore, Stephen P. Denyer
Copy: archive ↩︎